60 Degrees Pharmaceuticals's common stock is $260.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
60 Degrees Pharmaceuticals (SXTP) currently reports a common stock of $260 as of June 2026. That compares with $150 in the prior-year period — up 79.6% year over year. Use the charts on this page to explore 60 Degrees Pharmaceuticals's common stock history and peer comparisons.
60 Degrees Pharmaceuticals's common stock increased from $150 to $260 — a 79.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
60 Degrees Pharmaceuticals reported $260 in common stock as of June 2026. That compares with $150 in the prior-year period — up 79.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current common stock of $260, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for 60 Degrees Pharmaceuticals, and consider following SXTP for alerts when major investors trade the stock.